Oric Pharmaceuticals (ORIC) Retained Earnings (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Retained Earnings came in at -$728.0 million in Q1 2026, down 348425.36% YoY from N/an in Q1 2025, and down 5.17% on a QoQ basis from -$692.2 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Retained Earnings (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Retained Earnings data on file, last reported at -$728.0 million in Q1 2026.
- Quarterly Retained Earnings fell 348425.36% year-over-year to -$728.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$728.0 million (down 348425.36% YoY) and the FY2025 annual result came in at -$692.2 million, down 23.01% from the prior year.
- Retained Earnings slipped to -$728.0 million in Q1 2026, from -$692.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $209000.0 in Q1 2025 to a low of -$728.0 million in Q1 2026.
- A 5-year average of -$385.7 million and a median of -$434.9 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2025 — Retained Earnings soared 100.05% — and 2026, when it slumped 348425.36%.
- Tracing ORIC's Retained Earnings over 5 years: stood at -$1.3 million in 2022, then plunged by 33589.16% to -$434.9 million in 2023, then dropped by 29.4% to -$562.8 million in 2024, then slipped by 23.01% to -$692.2 million in 2025, then decreased by 5.17% to -$728.0 million in 2026.
- The last three Retained Earnings figures came in at -$728.0 million (Q1 2026), -$692.2 million (Q4 2025), and -$661.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -769.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -769.50 Mn |
| Mar 31, 2026 | -728.00 Mn |
| Dec 31, 2025 | -692.24 Mn |
| Sep 30, 2025 | -661.70 Mn |
| Jun 30, 2025 | -629.20 Mn |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | -562.77 Mn |
| Sep 30, 2024 | -526.50 Mn |
| Jun 30, 2024 | -491.90 Mn |
| Mar 31, 2024 | -459.94 Mn |
| Dec 31, 2023 | -434.93 Mn |
| Sep 30, 2023 | -406.60 Mn |
| Jun 30, 2023 | -567,000.00 |
| Mar 31, 2023 | -358.18 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -313.38 Mn |
| Jun 30, 2022 | -288.55 Mn |
| Mar 31, 2022 | -802,000.00 |
| Dec 31, 2021 | -245.11 Mn |
| Sep 30, 2021 | -222.34 Mn |